A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis
Public ClinicalTrials.gov record NCT01962987. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled, Parallel Design Study Comparing Diclofenac Sodium Gel 3% (Actavis) to Solaraze ® (Diclofenac Sodium) Gel 3% (Fougera Pharms) in the Treatment of Actinic Keratosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To compare the relative efficacy and safety of the test formulation diclofenac sodium gel 3% (Actavis) to the marketed formulation Solaraze® (diclofenac sodium) Gel 3% (Fougera Pharms) in the treatment of the actinic keratosis
Study identification
- NCT ID
- NCT01962987
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 476 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2013 (Type not available)
- Primary completion
- Sep 2013 (Actual)
- Completion
- Sep 2013 (Actual)
- Last update posted
- Jul 20, 2020
2013
United States locations
- U.S. sites
- 31
- U.S. states
- 17
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigator Site 23 | Fremont | California | — | — |
| Investigator Site 9 | Long Beach | California | — | — |
| Investigator Site 12 | Newport Beach | California | — | — |
| Investigator Site 2 | San Diego | California | — | — |
| Investigator Site 24 | San Ramon | California | — | — |
| Investigator Site 14 | Denver | Colorado | — | — |
| Investigator Site 17 | Denver | Colorado | — | — |
| Investigator Site 21 | Brandon | Florida | — | — |
| Investigator Site 25 | Dunedin | Florida | — | — |
| Investigator Site 20 | Fort Myers | Florida | — | — |
| Investigator Site 15 | Jacksonville | Florida | — | — |
| Investigator Site 16 | Miami | Florida | — | — |
| Investigator Site 6 | Ormond Beach | Florida | — | — |
| Investigator Site 19 | Winter Park | Florida | — | — |
| Investigator Site 22 | Atlanta | Georgia | — | — |
| Investigator Site 11 | Boise | Idaho | — | — |
| Investigator Site 8 | Arlington Heights | Illinois | — | — |
| Investigator Site 28 | Plainfield | Indiana | — | — |
| Investigator Site 31 | Louisville | Kentucky | — | — |
| Investigator Site 27 | Fridley | Minnesota | — | — |
| Investigator Site 13 | Bozeman | Montana | — | — |
| Investigator Site 26 | New Bern | North Carolina | — | — |
| Investigator Site 3 | Raleigh | North Carolina | — | — |
| Investigator Site 18 | Wilmington | North Carolina | — | — |
| Investigator Site 30 | Cincinnati | Ohio | — | — |
| Investigator Site 1 | Hazleton | Pennsylvania | — | — |
| Investigator Site 5 | Clinton | South Carolina | — | — |
| Investigator Site 4 | Johnson City | Tennessee | — | — |
| Investigator Site 10 | Nashville | Tennessee | — | — |
| Investigator Site 7 | West Jordan | Utah | — | — |
| Investigator Site 29 | Midlothian | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01962987, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 20, 2020 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01962987 live on ClinicalTrials.gov.